Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study

Fig. 1

Serum CTACK levels in the discovery cohort (n = 100), validation cohort (n = 81), and controls (n = 32). Serum CTACK levels in the discovery [median (interquartile range), 620.9 (491.6–778.0) pg/mL] and the validation [619.5 (436.5–837.9) pg/mL] cohorts were higher than those in controls [434.1 (308.7–521.0) pg/mL]. The discovery cohort and the control group were compared using an analysis of covariance to adjust for age, sex, and smoking history, and the results were corrected by the False Discovery Rate (FDR) method. * P < 0.05

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us